Similar articles

• Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection.

  Kahlert C, Hupfer M, Wagels T, Bueche D, Fierz W, Walker UA, Vernazza PL. Kahlert C, et al. AIDS. 2004 Apr 9;18(6):955-7. doi: 10.1097/00002030-200404090-00017. AIDS. 2004. PMID: 15060447 No abstract available.
• Anti-HIV agents. Indinavir--3 years and still going strong.

  [No authors listed] [No authors listed] TreatmentUpdate. 2000 Sep;12(6):3-4. TreatmentUpdate. 2000. PMID: 12132460 Clinical Trial. No abstract available.
• A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study.

  Carr A, Chuah J, Hudson J, French M, Hoy J, Law M, Sayer D, Emery S, Cooper DA. Carr A, et al. AIDS. 2000 Jun 16;14(9):1171-80. doi: 10.1097/00002030-200006160-00014. AIDS. 2000. PMID: 10894281 Clinical Trial.
• [Revised guideline "Antiretroviral Treatment"].

  Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren. Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren. Ned Tijdschr Geneeskd. 2005 Oct 22;149(43):2399-405. Ned Tijdschr Geneeskd. 2005. PMID: 16277129 Review. Dutch.
• [HIV protease inhibitors. A new drug class in antiretroviral therapy].

  Mauss S, Seidlitz B, Jablonowski H, Häussinger D. Mauss S, et al. Dtsch Med Wochenschr. 1996 Nov 1;121(44):1369-74. doi: 10.1055/s-2008-1043155. Dtsch Med Wochenschr. 1996. PMID: 8964223 Review. German. No abstract available.